OUR BIOINK TECHNOLOGY
Compatible with multiple bioprinters
High cell viability post printing
Beta tested by industry leaders
Xeno-free
Reduces time and labor costs
Designed for use with fragile cells
AWARDS & RECOGNITION
MEET THE TEAM
Dr. Stephanie Willerth
~
CEO
Dr. Willerth is a full professor of Biomedical Engineering who runs an active research group that investigates how to engineer neural tissue from pluripotent stem cells. Her research group has developed many types of biomaterial scaffolds for promoting the differentiation of induced pluripotent stem cells (iPSCs) into neural phenotypes for tissue engineering applications, such as screening the toxicity of drugs, learning about how tissues form during development and replacing dysfunctional tissues. She founded Axolotl Biosciences with the goal of bioprinting neural tissues easily accessible to scientists and engineering from a range of backgrounds.
Dr. Laura De La Vega
~
Co-Founder
Dr. Laura De La Vega is a scientist and bioengineer who's passionate about basic, translational science and innovative technologies. She holds expertise in the fields of stem cells, biomaterials, and biotechnology involving the development of technological applications using biological systems. She completed her PhD at the University of Victoria where she developed novel techniques for engineering neural tissue under the direction of Dr. Willerth. Her goal in co-founding Axolotl Biosciences is to optimize bioinks for multiple bioprinting platforms and address customer needs within the 3D bioprinting industry.
SUPPORTED BY:
%20(1).png)
PUBLICATIONS
CHECK OUT OUR SOCIAL MEDIA
